Apply Now

IBMS Graduate Student Among Winners of the 2018 Walther Cancer Foundation Grants

Author: Cheryl Schairer

Walther Grants Header

We would like to extend our congratulations to the awardees of the 2018 Walther Cancer Foundation Interdisciplinary Interface Training Program (IITP) grants. The IITP funding mechanism aims to establish cancer-focused integrative interdisciplinary training environment, provide support for highly qualified and productive applicants, and demonstrate efficacy of this training model to support future NIH T32 application.  


Elizabeth Harper, one of the IITP grant awardees, is a student in the Integrated Biomedical Sciences Graduate Program. Harper was awarded funding for her project, "The Role of Aging Peritoneum on Ovarian Cancer Metastasis".


The Cancer Cure Venture Grants will be announced in September. The overall goals of the CCV funding mechanism is to stimulate novel multi-disciplinary integrative cancer research, seed collaborative interactions between at least 2 scientific fields, provide cross-disciplinary training environment for post-doctoral fellows, and generate high quality preliminary data for extramural application.



Student: Elizabeth Harper


Mentors: Sharon Stack, Ann F. Dunne and Elizabeth Riley Director of Harper Cancer Research Institute, Kleiderer-Pezold Professor of Chemistry & Biochemistry; Brian Blagg, Director of Warren Family Research Center for Drug Discovery and Development, Charles Huisking Professor of Chemistry and Biochemistry


Project Title: The Role of Aging Peritoneum on Ovarian Cancer Metastasis


Student: Tyler Finamore


Mentors: Ryan Roeder, Professor of Aerospace and Mechanical Engineering, Bioengineering Graduate Program; Laurie Littlepage, Campbell Family Assistant Professor of Cancer Research, Assistant Professor Chemistry and Biochemistry


Project Title: Disruption of Microcalcification-Induced Tumorigenesis Using Bisphosphonate-Functionalized Gold Nanoparticles




Adapted from an article originally published by Khoa Huynh at on August 20, 2018.